Search clinical trials for: IDO1 inhibitor INCB024360
Total 64020 results
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelodysplastic SyndromesUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube Cancer | Stage IIA Fallopian Tube Cancer | Stage IIB Fallopian Tube Cancer | Stage IIC Fallopian Tube Cancer | Stage... and other conditions
-
Centre Hospitalier Universitaire de NīmesUniversidad Autonoma de MadridRecruitingSuicidal Behavior | Polymorphism | KynureninaseFrance, Spain
-
Richard D. CarvajalCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbTerminatedGlioblastoma | Glioblastoma MultiformeUnited States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
Edward KimBristol-Myers Squibb; National Cancer Institute (NCI)TerminatedUnresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma... and other conditionsUnited States
-
Aduro Biotech, Inc.Incyte CorporationTerminatedPlatinum-resistant Ovarian Cancer | Platinum-resistant Fallopian Cancer | Platinum-resistant Peritoneal CancerUnited States, Canada
-
Incyte CorporationCompletedUnresectable or Metastatic Solid TumorsUnited States
-
Incyte CorporationNovartis PharmaceuticalsCompletedSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Fallopian Tube Cancer AJCC v7 | Stage III Ovarian Cancer AJCC v6 and v7 | Stage III Primary Peritoneal Cancer AJCC v7 | Stage IIIA Fallopian Tube Cancer AJCC v7 | Stage IIIA Ovarian Cancer AJCC v6 and v7 | Stage IIIA Primary Peritoneal Cancer AJCC v7 | Stage IIIB Fallopian Tube Cancer... and other conditionsUnited States
-
Lei LiRecruitingEpithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival PrognosisChina
-
Thomas Jefferson UniversityBristol-Myers SquibbActive, not recruitingLarynx | Squamous Cell Carcinoma | Lip | Oral Cavity Squamous Cell Carcinoma | PharynxUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Incyte CorporationAstraZenecaCompletedHead and Neck Cancer | Lung Cancer | Solid Tumors | UC (Urothelial Cancer)United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte Corporation; University of VirginiaCompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Mucosal Melanoma | Stage IV Uveal Melanoma | Stage IIIA Skin Melanoma | Stage IIIA Uveal Melanoma | Stage IIIB Uveal Melanoma | Stage IIIC Uveal Melanoma | Recurrent Uveal MelanomaUnited States
-
Incyte CorporationHoffmann-La Roche; Genentech, Inc.TerminatedUC (Urothelial Cancer) | NSCLC (Non-small Cell Lung Carcinoma)United States
-
Peking UniversityRecruitingAdvanced Malignant Solid Tumor of Digestive SystemChina
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedMelanoma | Lymphoma | Head and Neck Cancer | Gastric Cancer | Ovarian Cancer | Hepatocellular Carcinoma (HCC) | Lung Cancer | Bladder Cancer | Endometrial Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | UC (Urothelial Cancer) | Microsatellite-instability (MSI) High Colorectal...United States
-
Incyte Biosciences International SàrlTerminatedMetastatic Cancer | Advanced MalignanciesUnited States
-
Bristol-Myers SquibbCompleted
-
Incyte CorporationTerminated
-
Peking UniversityHangzhou DIAN Medical Diagnostic Center Co., Ltd., ChinaRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Gastrointestinal Stromal Tumors | Neuroendocrine Tumors | Esophageal Squamous Cell Carcinoma | Biliary Tract Neoplasms | Unknown Primary Cancer | Digestive CancerChina
-
University of ChicagoTerminatedHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Incyte CorporationRecruitingRectal CancerUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, Spain, Hungary, Israel, United Kingdom, Korea, Republic of, Taiwan, Denmark, France, Netherlands, Italy, Canada, Japan, Turkey, Germany, Ireland, Australia, Russian Federation
-
Georgetown UniversityMerck Sharp & Dohme LLC; Incyte CorporationUnknownThymic Carcinoma | Thymus Neoplasms | Thymus CancerUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedLung CancerSpain, Ireland, Canada, Denmark, Japan, Israel, Korea, Republic of, Malaysia, United States, Turkey, Italy, Ukraine, Switzerland, Russian Federation, Poland, Australia, Estonia, United Kingdom
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, France, Belgium, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Australia, Netherlands, Japan, Germany, Ukraine, Canada, Ireland, Italy, Poland, Russian Federation
-
Incyte CorporationTerminated
-
George Albert FisherMerck Sharp & Dohme LLCCompletedGastric Adenocarcinoma | Recurrent Esophageal Carcinoma | Recurrent Gastric Carcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Stage IV Gastric Cancer AJCC v7 | Unresectable Esophageal CarcinomaUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedLung CancerUnited States, Hungary, Spain, Ireland, Italy, Taiwan, Korea, Republic of, United Kingdom, Turkey, Canada, Israel, Australia, Mexico, Russian Federation
-
Vanderbilt-Ingram Cancer CenterAstex Pharmaceuticals, Inc.; Forma Therapeutics, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome
-
Massachusetts General HospitalFenway Community Health; National Institute of Drug AbuseRecruitingHiv | Substance Use DisordersUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...WithdrawnMuscle-invasive Bladder CancerItaly
-
Mingge LLCFudan University; Huashan HospitalActive, not recruitingGlioma, Malignant | Computer-AssistedChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnPancreatic Ductal Adenocarcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Homologous Recombination Deficiency | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | ATM Gene Mutation | Deleterious BRCA1 Gene... and other conditions
-
Sohag UniversityCompletedSpontaneous Bacterial PeritonitisEgypt
-
Inge Marie SvaneCompletedNSCLC | Lung CancerDenmark
-
Regina Elena Cancer InstituteUniversity of Roma La Sapienza; Fondazione I.R.C.C.S. Istituto Neurologico... and other collaboratorsActive, not recruiting
-
National Center for Tumor Diseases, HeidelbergGerman Cancer Research Center; University Hospital Heidelberg; Neuro-Oncology...Completed
-
University of California, DavisNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedRecurrent Non-small Cell Lung CancerUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCActive, not recruitingRenal Cell Carcinoma (RCC)Canada, France, United States, Spain, United Kingdom, Italy, Taiwan, Australia, Norway, Korea, Republic of, Germany, Russian Federation, Japan, Brazil, Turkey, Ukraine, Hungary, New Zealand, Chile, Ireland
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Ovarian Carcinoma | Malignant Ovarian Clear Cell TumorUnited States, Puerto Rico
-
James J LeeMerck Sharp & Dohme LLC; Incyte CorporationWithdrawnMetastatic Colorectal CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnEsophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Incyte CorporationTerminated
-
Dynavax Technologies CorporationCompletedHepatitis BUnited States
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States